Purdue Pharma faces its final legal milestone as criminal sentencing approaches, potentially marking the end of the opioid manufacturer's operations. The pharmaceutical company is expected to be restructured into a public benefit entity by week's end, following a comprehensive settlement addressing thousands of opioid crisis lawsuits. This transformation represents a significant accountability measure in the ongoing battle against prescription drug abuse and corporate responsibility in the healthcare industry.

Summary auto-generated by AI from the original publisher's content. Editorial standards.